A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Clinical trial NCT05418868 · RECRUITING
Trial details
- NCT number
- NCT05418868
- Sponsor
- ViiV Healthcare
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2027-06-08
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.